Natco Pharma seeks USFDA nod for hepatitis drug
Natco Pharma has filed an abbreviated new drug application (ANDA) for Sofosbuvir Tablets, 400mg, with the United States Food and Drug Administration (USFDA). The company...
Tag : Natco Pharma
Natco Pharma’s Mekaguda facility clears USFDA inspection
Natco Pharma’s, Mekaguda facility near Hyderabad, has received zero observations from the US health regulator. The company in its filing stated, “….announce successful completion of regulatory...
Natco Pharma receives approval from board to raise Rs.1,500 cr
Natco Pharma has received approval from board to raise Rs.1,500 crore via sale of shares to investors. In a filing to the exchange it stated,...
Natco Pharma has received EIR from USFDA for Kothur Facility
Natco Pharma has received the establishment inspection report (EIR) for its Kothur facility in Telangana from the US health regulator after successful completion of inspection....
Natco Pharm has launched generic hepatitis C drug in India
Natco Pharma has launched generic sofosbuvir 400 mg/velpatasvir 100 mg tablets that are used in treatment of chronic hepatitis C, in India. Natco Pharma has...
Natco Pharma has received USFDA approval for leukemia drug
On Friday, Natco Pharma has said that it has received the USFDA approval for manufacturing a drug for injections that are used in the treatment...
Natco Pharma has launched Tamiflu generic capsules in US
Natco Pharma, after receiving final approval from the US health regulator in August this year, launched a generic Tamiflu capsules that are used in the...
Natco Pharma has received USFDA approval for generic Budesonide capsules
Natco Pharma has got the US health regulator’s approval for generic version of Budesonide capsules that are used for treatment of active Crohn’s disease for...
Natco Pharma reports net up of 69.7% for Q1 to Rs 47.65 crore
Natco Pharma has posted 69.75 percent rise in the consolidated net profit to Rs 47.65 crore for the first quarter ended June 30, 2016. During...
Natco Pharma’s partner MylanInc has received USFDA’s approval for cancer drug
Natco Pharma has said that its marketing partner Mylan Inc has got tentative approval from the US health regulator for selling generic Sorafenib tablets that...